Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal remifentanil versus intranasal lidocaine for hemodynamic control during laryngeal mask airway insertion
IRCT20180416039326N10Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in None comparing Intranasal remifentanil with Intranasal lidocaine (2 arms). Primary endpoints: Heart rate, Systolic blood pressure and 3 more. Started Jan 2019; status: completed.
02
Drugs
remifentanillidocaine
Beyond the preview
Go deeper on IRCT20180416039326N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180416039326N10.